Fengzhen Wang
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- RNA Interference and Gene Delivery 8
- Lipid Membrane Structure and Behavior 4
-
- High Temperature Alloys and Creep 10
- Microstructure and Mechanical Properties of Steels 8
- Co-authors
- Juan Li (2 shared papers)Dongsheng Zhang (2 shared papers)Jun Hu (1 shared paper)Shuwei Wang (1 shared paper)Qunwei Xu (7 shared papers)Sunmin Jiang (6 shared papers)Hu‐Lin Jiang (7 shared papers)Lei Xing (6 shared papers)
- Journals
- Journal of Materials Research and Technology (4 papers)International Journal of Pharmaceutics (4 papers)Biomaterials (3 papers)Intermetallics (2 papers)Journal of drug targeting (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Fengzhen Wang
75 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 150
- Pharmaceutical Science 222
- Cancer Research 252
- Biomaterials 178
- Molecular Biology 626
- Nephrology 36
Countries citing papers authored by Fengzhen Wang
This map shows the geographic impact of Fengzhen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengzhen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengzhen Wang more than expected).
Fields of papers citing papers by Fengzhen Wang
This network shows the impact of papers produced by Fengzhen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengzhen Wang. The network helps show where Fengzhen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengzhen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 366 | |
| 2 | 2020 | 103 | |
| 3 | 2015 | 98 | |
| 4 | 2014 | 66 | |
| 5 | 2013 | 65 | |
| 6 | 2010 | 59 | |
| 7 | 2016 | 56 | |
| 8 | 2010 | 52 | |
| 9 | 2013 | 52 | |
| 10 | 2018 | 47 | |
| 11 | 2014 | 44 | |
| 12 | 2020 | 42 | |
| 13 | 2013 | 30 | |
| 14 | 2015 | 27 | |
| 15 | 2014 | 24 | |
| 16 | 2013 | 24 | |
| 17 | 2016 | 23 | |
| 18 | 2021 | 21 | |
| 19 | Pirfenidone inhibits epidural scar fibroblast proliferation and differentiation by regulating TGF-β1-induced Smad-dependent and -independent pathways. | 2019 | 19 |
| 20 | 2021 | 17 |
About Fengzhen Wang
Fengzhen Wang is a scholar working on Molecular Biology, Mechanical Engineering, Plant Science, Pharmaceutical Science and Mechanics of Materials, having authored 89 papers that have together received 1.5k indexed citations. Recurring topics across this work include High Temperature Alloys and Creep (10 papers), Microstructure and Mechanical Properties of Steels (8 papers), Mycorrhizal Fungi and Plant Interactions (8 papers), RNA Interference and Gene Delivery (8 papers), Advanced Drug Delivery Systems (7 papers), Advancements in Transdermal Drug Delivery (5 papers), Metallurgy and Material Forming (5 papers) and Lipid Membrane Structure and Behavior (4 papers). The work is most often cited by research in Pharmaceutical Science (222 citations), Cancer Research (252 citations), Biomaterials (178 citations), Molecular Biology (626 citations) and Nephrology (36 citations). Fengzhen Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Juan Li, Dongsheng Zhang, Jun Hu, Shuwei Wang, Qunwei Xu, Sunmin Jiang, Hu‐Lin Jiang, Lei Xing, Peng‐Fei Cui and Dong Sun. Their work appears in journals such as Journal of Materials Research and Technology, International Journal of Pharmaceutics, Biomaterials, Intermetallics and Journal of drug targeting.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.